Provista Diagnostics Joins Cancer Moonshot-Inspired Collaborative to Advance Blood Tests for Cancer
13 déc. 2016 08h00 HE
|
Provista Diagnostics, Inc.
NEW YORK, Dec. 13, 2016 (GLOBE NEWSWIRE) -- Provista Diagnostics has joined a new collaborative announced in response to the White House Cancer Moonshot, the Blood Profiling Atlas. The Atlas is a...
New blood-based diagnostic test for breast cancer demonstrates detection power of protein biomarkers irrespective of breast density
06 déc. 2016 08h00 HE
|
Provista Diagnostics, Inc.
NEW YORK, Dec. 06, 2016 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc., today announced that it will present exhibit posters at the San Antonio Breast Cancer Symposium (SABCS), taking place December...
Provista Diagnostics to present at Key Healthcare Conferences in New York and Boston
15 nov. 2016 08h00 HE
|
Provista Diagnostics, Inc.
NEW YORK, Nov. 15, 2016 (GLOBE NEWSWIRE) -- Provista Diagnostics Inc., will be presenting at the Canaccord Genuity Medical Technology & Diagnostics Forum in New York as well as the Evercore ISI...
Early Breast Cancer Detection Test Unaffected by Breast Density in Women 25 – 75
19 sept. 2016 17h00 HE
|
Provista Diagnostics, Inc.
NEW YORK, Sept. 19, 2016 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc., today announces that David Reese, Ph.D., President and Chief Executive Officer, will deliver a poster presentation at the...
Provista Diagnostics Appoints Judith K. Wolf, M.D., as Chief Medical Officer
28 juil. 2016 09h00 HE
|
Provista Diagnostics, Inc.
NEW YORK, July 28, 2016 (GLOBE NEWSWIRE) -- Provista Diagnostics Inc., a company developing and commercializing protein-based diagnostic, prognostic and monitoring tests for cancers affecting women,...
Breast Cancer Blood Test Now Accessible Under Health Benefits for Millions of Women in the U.S.
07 juil. 2016 09h00 HE
|
Provista Diagnostics, Inc.
NEW YORK, July 07, 2016 (GLOBE NEWSWIRE) -- Provista Diagnostics, a private company developing and commercializing protein-based diagnostic, prognostic and monitoring tests for cancers affecting...
Provista Diagnostics Announces Positive Trial Results Assessing the Use of Videssa® Breast to Detect Breast Cancer
02 juin 2016 08h00 HE
|
Provista Diagnostics, Inc.
NEW YORK, June 02, 2016 (GLOBE NEWSWIRE) -- Provista Diagnostics, a company developing and commercializing proteomic-based diagnostic, prognostic and monitoring tests for cancers affecting women,...
Provista Diagnostics to Present at The 2016 BIO International Convention
24 mai 2016 12h00 HE
|
Provista Diagnostics, Inc.
New York, NY, May 24, 2016 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc., today announces that David Reese, Ph.D., President and Chief Executive Officer, will deliver a corporate overview at...
Provista Diagnostics Announces New Chief Financial Officer and Expands Commercial Team Expertise
06 avr. 2016 09h00 HE
|
Provista Diagnostics, Inc.
New York, April 06, 2016 (GLOBE NEWSWIRE) -- Provista Diagnostics Inc., a company developing and commercializing molecular diagnostic, prognostic and monitoring tests for cancers affecting women,...
Provista Diagnostics Closes $5.25 Million Financing
21 mars 2016 09h00 HE
|
Provista Diagnostics, Inc.
New York, March 21, 2016 (GLOBE NEWSWIRE) -- NEW YORK, NY – March 21, 2016 - Provista Diagnostics, Inc., a company developing and commercializing proteomic-based diagnostic, prognostic and...